Skip to content

PHARMAKAISER GRIVEGNEE

Active
Private limited companyfounded 2021active for 5 yearsRue Fraischamps 24, 4030 Liège, BelgiumKBO/BCE: BE 0774.285.474
Summary

The computed 12-month bankruptcy probability of PHARMAKAISER GRIVEGNEE is 2.0% (moderate). The 2025 annual accounts show equity of €260,961 and a net result of -€67,727. Equity is shrinking by about 3.6% per year across the filed financial years. Its solvency ranks better than 33% of 12,482 sector peers (NACE 47, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.2mtotal assets 2025
Staff
3 FTE
Equity
€260,961
Loss
-€67,727
Financial health
53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.0%
Structure
Largest shareholder
ANNE-SOPHIE KAISER GESTION · 50%
Accounts filed 31 days late0 of 1 deed read
Why 53raises riskLatest accounts 31 days late; 1 of the last 3 lateLoss of €67,727, the second in a row (financial year 2025)Founded in 2021lowers riskSize: 3 FTE, total assets €1.2mShow the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 32% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 47-38
equity 21.6% of total assets
Liquidity 51-12
short-term debt 17.0% · cash 4.0%
Profitability 13-17
return on assets -5.6%
Bankruptcy probability, 12 months
2.0% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,186 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025lowest value 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.4%▲ +0.1 percentage points vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.8%▲ +0.3 percentage points vs 07-2026 09-2026: 2.0%▲ +1.2 percentage points vs 08-2026highest value 10-2026: 2.0%● unchanged vs 09-2026highest value
Credit of up to €13,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.75, compared with 3.81 in 2024; short-term debt: 17% and cash: 4% of total assets), but 78.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 37% on solvency, 54% on liquidity, 19% on profitability and 19% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
raises risk · Latest accounts 31 days late; 1 of the last 3 late
NBB · filings
raises risk · Loss of €67,727, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Size: 3 FTE, total assets €1.2m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Founded in 2021
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
22232425
2022 to 2025 · latest year -€67,727
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
31 days late
2024
44 days early
2023
2 days early
2022
2 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 3 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 August (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Weakest financial yearnet -€67,727
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Caution: Result fell in 2025from -€4,245 to -€67,727 ▼ 1,495% View
  • Caution: Among the weakest 8% on net resultsector median €28,206 · 12,471 companies -€67,727 View
  • Caution: 2 loss-making years in a rowloss financial year 2025 -€67,727 View

By topic

Financials

Financial year
2025
Total assets
€1.2m
Loss
-€67,727
Solvency
21.6%
Total assets▲ 121%
Net result
20222025
Go to Financials

Timeline

Events
6
Since
2023
Next accounts
by 31-07-2027
  1. 29-07-2024Annual accounts filed
  2. 31-12-2023Highest result from 2022 to 2025
  3. 02-08-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
17-09-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.